In medical news:

Government spending on compound drugs has skyrocketed in recent years, drawing the attention of federal investigators who are raising fraud and overbilling concerns. The federal workers’ compensation program has also seen a recent spike, and compound med spending in Medicare’s Part D program, rose 56 percent last year. The jump, along with a sharp increase in the number of patients getting the compounded drugs “may indicate an emerging fraud trend,” according to a June report on the Medicare spending by the inspector general’s office at the Department of Health and Human Services.

Read complete coverage via Kaiser Health News here.

Leave a Comment

Your email address will not be published. Required fields are marked *